Vestal Point Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Vestal Point Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-350,000	Closed	-$13.9M	–	79
2024 Q1	$13.9M	Buy	+350,000	New	+$10.3M	1.15%	21

Vestal Point Capital's ALPN Position: Q2 2024 in Review

Vestal Point Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 350,000 shares — an estimated $13.9M sold.

Vestal Point Capital first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $13.9M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Vestal Point Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Vestal Point Capital sold 350,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $13.9M.
Vestal Point Capital first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Vestal Point Capital's Alpine Immune Sciences Inc position peaked at $13.9M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Vestal Point Capital's 13F filing for Q2 2024, filed 14 Aug 2024.